NASDAQ · HYPR
Healthcare · Medical - Devices
$0.77
Down-$0.03 (-3.37%)
Updated Sep 17, 2026, 2:13 AM
SID Score
3.1/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance
1M range · 20 trading sessions · Daily adjusted prices
HYPR closed at $0.77 after 20 trading sessions, down 14.15% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 16, 2026 | $0.785 | $0.8014 | $0.7726 | $0.7742 | 327.94K |
| Sep 15, 2026 | $0.8153 | $0.8156 | $0.79 | $0.8012 | 284.15K |
| Sep 14, 2026 | $0.7929 | $0.8139 | $0.7751 | $0.804 | 428.97K |
| Sep 11, 2026 | $0.8114 | $0.8114 | $0.7807 | $0.7901 | 189.05K |
| Sep 10, 2026 | $0.791 | $0.8235 | $0.7802 | $0.7864 | 249.47K |
| Sep 9, 2026 | $0.81 | $0.8259 | $0.7859 | $0.7909 | 498.08K |
| Sep 8, 2026 | $0.83 | $0.8388 | $0.81 | $0.8218 | 258.57K |
| Sep 4, 2026 | $0.82 | $0.8331 | $0.80 | $0.8133 | 524.61K |
| Sep 3, 2026 | $0.83 | $0.8437 | $0.8026 | $0.837 | 606.49K |
| Sep 2, 2026 | $0.8244 | $0.8303 | $0.7916 | $0.806 | 519.55K |
| Sep 1, 2026 | $0.825 | $0.8297 | $0.807 | $0.8107 | 242.08K |
| Aug 31, 2026 | $0.8311 | $0.8416 | $0.8125 | $0.8243 | 311.9K |
| Aug 28, 2026 | $0.8518 | $0.8571 | $0.8311 | $0.8332 | 326.41K |
| Aug 27, 2026 | $0.88 | $0.885 | $0.8344 | $0.8454 | 550.08K |
| Aug 26, 2026 | $0.8877 | $0.8877 | $0.831 | $0.8681 | 571.34K |
| Aug 25, 2026 | $0.86 | $0.8796 | $0.8501 | $0.8698 | 456.6K |
| Aug 24, 2026 | $0.9108 | $0.9112 | $0.85 | $0.8563 | 633.58K |
| Aug 21, 2026 | $0.92 | $0.92 | $0.8801 | $0.9021 | 532.21K |
| Aug 20, 2026 | $0.8963 | $0.9273 | $0.8827 | $0.9041 | 741.65K |
| Aug 19, 2026 | $0.903 | $0.93 | $0.882 | $0.9018 | 478.17K |
The latest Smart Investors Daily articles mentioning HYPR.
HYPR research
Company profile and research snapshot.
Hyperfine Inc is a medical device company that created Swoop. The Swoop Portable MR Imaging System produces high-quality images at a lower magnetic field strength than conventional MRI scanners. The company derives its revenue from sale of sales of MRI devices and service sales which consist of sales from subscriptions of bundled devices, maintenance, and software.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Sep 14, 2026 | BTIG | Buy | — |
| Aug 10, 2026 | B. Riley Securities | Buy | — |
| Apr 29, 2026 | BTIG | Buy | — |
| Mar 19, 2026 | Lake Street | Buy | — |
| Aug 15, 2025 | Wells Fargo | Equal-Weight | — |
No generated briefing is available yet.
Benzinga · Apr 9, 2026
This milestone unlocks Hyperfine's most significant technology innovations to date for clinicians and patients across Europe and the United Kingdom, delivering a transformative leap in image quality and a major expansion
Benzinga · Jan 27, 2026
Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable MRI system for the brain—the Swoop® system—today announced
businesswire.com · Nov 20, 2025
GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine announces plans to present at the upcoming Piper Sandler 37th Annual Healthcare Conference on Thursday, December 4th at 8:10 AM ET.
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning HYPR.
No results
No recent SID articles mention HYPR.
